Filing Details

Accession Number:
0000899243-22-014548
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-12 16:05:43
Reporting Period:
2022-04-08
Accepted Time:
2022-04-12 16:05:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1215126 G Margaret Mcglynn C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-08 5,000 $127.54 6,099 No 4 M Direct
Common Stock Disposition 2022-04-08 4,900 $280.19 1,199 No 4 S Direct
Common Stock Disposition 2022-04-08 100 $281.49 1,099 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-04-08 5,000 $0.00 5,000 $127.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2025-05-31 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1.
  2. Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $280.19 (range $280.00 to $280.95).
  4. Fully vested.